Olea Medical has been acquired by Toshiba Medical Systems Corp.
The private shareholders of Olea Medical have sold the company to Toshiba Medical Systems Corporation, a wholly-owned subsidiary of Toshiba. Financial details have not been disclosed.
Olea Medical designs and markets innovative medical imaging applications that significantly improve diagnostic processes and treatment evaluation. Created in July 2008, the company has continuously increased its portfolio of innovative vendor-neutral software applications for MRI and CT imaging post-processing, including emergency settings dedicated ones. Olea Medical's competitive solutions allow them to speed up and enhance diagnosis process and are now implemented in major health care centers all over the world, and the company aims to become the leading provider of safe and accurate medical imaging software.
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years.
Oaklins' team in France acted as the sole financial advisor to the seller in this transaction.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more